Table 2.
Comparison of serum GSH concentration, CAT, MDA concentration, between controls and gastric cancer patients.
| Univariate | CG | GC | p |
|---|---|---|---|
| GSH | 337.76 (112.18-561) | 125.72 (46.29-220.41) | <0.001 |
| CAT | 0.97 (0.69-1.42) | 0.95 (0.43-1.33) | 0.355 |
| MDA | 3.85 (3.33-6.47) | 6.32 (3.94-12.13) | 0.011 |
| SOD | 0.66 (0.58-0.77) | 0.6 (0.48-0.73) | 0.163 |
| Multivariate∗ | CG | GC | p |
| GSH | 325.5 (309.25-380.42) | 137.84 (125.98-157.91) | <0.001 |
| CAT | 1.04 (0.92-1.15) | 0.9 (0.79-1.05) | 0.329 |
| MDA | 5.44 (5.16-5.57) | 8.93 (8.53-9.43) | 0.001 |
| SOD | 0.67 (0.67-0.68) | 0.6 (0.59-0.61) | 0.189 |
∗Values estimated for generalized linear model gama-log: intercept, sex, smoking, cancer, and age. Data presented as median (25th percentile-75th percentile). CG control group and GC gastric cancer group.